ARS Pharmaceuticals, Inc (SPRY) short volume · rev $84.3M
ARS Pharmaceuticals, Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 266,732 | 385,861 | 69.1% |
| 2026-10-20 | 397,659 | 584,490 | 68.0% |
| 2026-10-19 | 419,579 | 590,163 | 71.1% |
| 2026-10-16 | 631,403 | 1,007,395 | 62.7% |
| 2026-10-15 | 304,847 | 823,158 | 37.0% |
| 2026-10-14 | 491,483 | 775,694 | 63.4% |
| 2026-10-13 | 359,569 | 624,090 | 57.6% |
| 2026-10-12 | 425,937 | 602,442 | 70.7% |
| 2026-10-09 | 199,446 | 398,396 | 50.1% |
| 2026-10-08 | 281,086 | 421,859 | 66.6% |
SPRY short volume FAQ
What was SPRY's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for ARS Pharmaceuticals, Inc (SPRY) was 266,732 shares, 69.1% of 385,861 total volume.
How many SPRY short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for ARS Pharmaceuticals, Inc (SPRY), from Oct 8, 2026 through Oct 21, 2026.
How did SPRY short volume percent change from the prior cached session?
Cached FINRA short volume for ARS Pharmaceuticals, Inc (SPRY) moved from 68.0% on Oct 20, 2026 to 69.1% on Oct 21, 2026, up 1.1 percentage points.
What was the highest SPRY short volume percent on this page?
The highest cached FINRA short volume on this page is 71.1% of total volume on Oct 19, 2026.
Where is SPRY listed?
ARS Pharmaceuticals, Inc (SPRY) common stock is listed on NASDAQ.
What is SPRY's latest revenue?
Latest cached ARS Pharmaceuticals, Inc (SPRY) revenue for Dec 31, 2025 was $84.3M. Statements: https://lician.com/financials/spry
What is the average SPRY short volume percent on this page?
Across 10 cached sessions on this page, ARS Pharmaceuticals, Inc (SPRY) short volume averaged 61.6% of total volume.
Where is SPRY short volume listed?
Cached FINRA short volume for ARS Pharmaceuticals, Inc (SPRY) is listed at https://lician.com/short-interest/spry.
Not investment advice. Cached rows, not a live tape.